Ignite Creation Date:
2025-12-25 @ 4:52 AM
Ignite Modification Date:
2026-01-24 @ 8:54 AM
Study NCT ID:
NCT01999218
Status:
COMPLETED
Last Update Posted:
2019-04-02
First Post:
2013-11-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ertugliflozin vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-12-16
Start Date Type:
ACTUAL
Primary Completion Date:
2017-04-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-04-18
Completion Date Type:
ACTUAL
First Submit Date:
2013-11-25
First Submit QC Date:
None
Study First Post Date:
2013-12-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-04-10
Results First Submit QC Date:
None
Results First Post Date:
2018-05-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-03-25
Last Update Post Date:
2019-04-02
Last Update Post Date Type:
ACTUAL